FDA
-
-
-
-
-
-
-
AMAG Pharma (AMAG) Reports Update on FDA Proposal Regarding Makena (Hydroxyprogesterone Caproate Injection)
-
-
-
-
-
-
-
AMAG Pharma (AMAG) and Norgine B.V. Enter Into Exclusive Licensing Agreement to Commercialize Ciraparantag in Europe, Australia and New Zealand
-
-
-
-
-
-
-
AMAG Pharmaceuticals Announces Third Quarter 2019 Financial ResultsĀ and Provides Corporate Update
-
-
-
-
-
-
-
AMAG Pharma (AMAG) Announces Publication of PROLONG Trial Evaluating 17-OHPC in American Journal of Perinatology
-
-
-
-
-
-
-
Pre-Open Movers 06/24: (PCMI) (NERV) (PTN) (DFRG) (CZR) (ERI) (BMY) (CELG) (SPOT) (more)
-
-
-
-
-
-
-
AMAG Pharma (AMAG) Reports Topline Results From the PROLONG Trial Evaluating Makena (hydroxyprogesterone caproate injection)
-
-
-
-
-
-
-
AMAG Pharma (AMAG) to Acquire Perosphere
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

